Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II. Evaluation in a variety of clinical conditions

British Journal of Haematology

Volumn 68, Issue 1, 1988, Pages 91-96

  Gaffney, P J ^a   Creighton, L J ^a   Callus, M ^a   Thorpe, R ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRIN DEGRADATION PRODUCT; MONOCLONAL ANTIBODY;

DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HUMAN; LUNG EMBOLISM; PREGNANCY; THROMBOSIS;

EID: 0023883101     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1988.tb04184.x     Document Type: Article

References (24)

1. Cash, J. D. (1966) Effect of moderate exercise on the fibrinolytic system in young men and women. British Medical Journal, ii, 502–506.
2. Ciernewski, C. S., Janiak, A., Nowak, P. & Augustiniak, W. (1982) Reactivity of fibrinogen derivatives with antisera to human fibrin D dimer and its γ‐γ remnant. Thrombosis and Haemostasis, 48, 33–37.
3. Collén, D. (1980) On the regulation and control of fibrinolysis. Thrombosis and Haemostasis, 77–89.
4. Donati, M. B. (1975) Assays for fibrinogen/fibrin degradation products in biological fluids: some methodological aspects. Thrombosis et Diathesis Haemorrhagica, 34, 652–660.
5. Elms, M. J., Bunce, I. H., Bundesen, P. G., Rylatt, D. B., Webber, A. J., Masci, P. P. & Whitaker, A. N. (1983) Measurement of crosslinked fibrin degradation products — an immunoasssay using monoclonal antibodies. Thrombosis and Haemostasis, 50, 591–594.
6. Gaffney, P. J. (1972) FDP. Lancet, ii, 1422.
7. Gaffney, P. J. (1983) The occurrence and clinical relevance of fibrin fragments in blood. Annals of the New York Academy of Science, 408, 407–423.
8. Gaffney, P. J., Brasher, M., Lord, K., Strachan, C. J. L., Wilkinson, A. R., Kakkar, V. V. & Scully, M. F. (1976) Fibrin subunits in venous and arterial thromboembolism. Cardiovascular Research, 421–426.
9. Gaffney, P. J., Creighton, L. J., Harris, R. & Perry, M. J. (1986) Monoclonal antibodies (Mabs) to crosslinked fibrin fragments: their characterisation and potential clinical use: G. Muller‐Berghaus, U. Scheefers‐Borchel, E. Selmayrs and A. Henschen (eds.): Fibrinogen and its Derivatives. Biochemistry, Physiology and Pathophysiology. Excerpta Medica, Amsterdam International Congress Series No. 722, pp. 245–256.
10. Gaffney, P. J., Creighton, L. J., Perry, M. J., Callus, M., Thorpe, R. & Spitz, M. (1988) Monoclonal antibodies to crosslinked fibrin degradation products (XL‐FDP). I. Characterization and preliminary evaluation in plasma. British Journal of Haematology, 68, 83–90.
11. Gaffney, P. J., Joe, F. & Mahmoud, M. (1980) Giant fibrin fragments derived from crosslinked fibrin: structure and clinical implication. Thrombosis Research, 20, 647–662.
12. Graeff, H., Haffer, R. & Bachmann, L. (1979) Subunit and macromolecular structures of circulating fibrin from obstetric patients with intravascular coagulation. Thrombosis Research, 16, 313–328.
13. Mahmoud‐Alexandroni, M. & Gaffney, P. J. (1987) Sensitive and direct assays for functionally active plasminogen activators (tissue‐type and urokinase‐type) in plasma. Thrombosis Research (in press).
14. Marsh, N. A. & Gaffney, P. J. (1982) Exercise‐induced fibrinolysis — fact or fiction Thrombosis and Haemostasis, 48, 201–203.
15. Merskey, C., Johnson, A. J. & Zalezari, P. (1972) Increase in fibrinogen and fibrin‐related antigen in human serum due to in vitro lysis of fibrin by thrombin. Journal of Clinical Investigation, 51, 903–911.
16. Mirshahi, M., Soria, J., Soria, C., Perrot, J. Y. & Boucheix, C. (1986. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody, Thrombosis Research, 44, 715–728.
17. Nieuwenhuizen, W. (1986) The use of monoclonal antibodies in demonstrating different fibrinogen derivatives. In: G. Muller‐Berghaus, U. Scheefers‐Borchel, E. Selmayr and A. Henschen (eds.): Fibrinogen and its Derivatives. Biochemistry, Physiology and Pathophysiology. Excerpta Medica, Amsterdam, International Congress Series No. 722, pp. 245–256.
18. Nossel, H., Wasser, J., Kaplan, K.L., La Gamma, K. S., Yudelman, I. & Canfield, R. E. (1979) Sequence of fibrinogen proteolysis and platelet release after intra‐arterial infusion of hypertonic saline. Journal of Clinical Investigation, 64, 1371–1378.
19. Perry, M. J. & Gaffney, P. J. (1985) Giant fibrin fragments and thrombosis. (Abstract). Thrombosis and Haemostasis, 54, 158.
20. Rogers, S., Sweetman, P. M., Perry, M. J. & Gaffney, P. J. (1985) Plasma levels of fibrin fragments in men with myocardial infarction. Thrombosis Research, 43, 389–393.
21. Rylatt, D. B., Blake, A. S., Cottis, L. E., Massingham, D. A., Fletcher, W. A., Masci, P. P., Whitaker, A. M., Elms, M., Bunce, I., Webber, A. J., Wyatt, D. & Bundesen, P. G. (1983) An immunoassay for human D dimer using monoclonal antibodies. Thrombosis Research, 31, 767–778.
22. Seifried, E., Rijken, C. C., Hoegee, B., Tanswell, P., Kluft, C. & Nieuwenhuizen, W. (1987) Fibrin degradation products (FbDP) in healthy volunteers after infusion of recombinant tissue‐type plasminogen activator (Rt‐PA). In: Fibrinogen/Fibrin Workshop, Glasgow, 6–8 April.
23. Whitaker, A. N., Elms, M. J., Masci, P. P., Bundesen, P. G., Rylatt, D. B., Webber, A. J. & Bunce, I. H. (1984) Measurement of crosslinked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies. Journal of Clinical Pathology, 37, 882–887.
24. Whitaker, A. N., Rowe, E. A., Masci, P. P. & Gaffney, P. J. (1980) Identification of D dimer‐E complex in disseminated intravascular coagulation. Thrombosis Research, 18, 453–459.